Stockreport

Artiva Biotherapeutics Announces Pricing of Upsized $167.0 Million Initial Public Offering

Artiva Biotherapeutics, Inc.  (ARTV) 
PDF SAN DIEGO, July 18, 2024 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, [Read more]